Melanie Claps

Milan, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications

Reducing the burden of active surveillance monitoring examinations in prostate cancer: Insights from real-world data to inform clinical practice.

Reducing the burden of active surveillance monitoring examinations in prostate cancer: Insights from real-world data to inform clinical practice.

Journal: Tumori
Published: August 25, 2026

Local treatment of the primary tumour in mHSPC in the ARPI era: incremental value or overtreatment?

Local treatment of the primary tumour in mHSPC in the ARPI era: incremental value or overtreatment?

Journal: Expert review of anticancer therapy
Published: June 10, 2026

Lynch syndrome-associated urothelial carcinoma: clinical and molecular findings from a single-institution cohort.

Lynch syndrome-associated urothelial carcinoma: clinical and molecular findings from a single-institution cohort.

Journal: Familial cancer
Published: June 01, 2026

177Lu-PSMA-617 radioligand therapy as an immune modulator in prostate cancer.

177Lu-PSMA-617 radioligand therapy as an immune modulator in prostate cancer.

Journal: Expert review of anticancer therapy
Published: May 06, 2026

Management of monorchid patients with previous testis cancer: the role of frozen sections and the real possibility of testis sparing surgery in a large retrospective series.

Management of monorchid patients with previous testis cancer: the role of frozen sections and the real possibility of testis sparing surgery in a large retrospective series.

Journal: Minerva urology and nephrology
Published: January 27, 2026

An update on the treatment paradigm for non-clear cell renal cell carcinoma.

An update on the treatment paradigm for non-clear cell renal cell carcinoma.

Journal: Expert review of clinical pharmacology
Published: January 10, 2026

Risk factors and causes of early death in germ cell tumors: a Global Society for Rare GU tumors study.

Risk factors and causes of early death in germ cell tumors: a Global Society for Rare GU tumors study.

Journal: British journal of cancer
Published: November 01, 2025

Salvage post-chemotherapy retroperitoneal lymph-node dissection: evolving paradigm for marker-positive non-seminomatous germ-cell tumors management.

Salvage post-chemotherapy retroperitoneal lymph-node dissection: evolving paradigm for marker-positive non-seminomatous germ-cell tumors management.

Journal: British journal of cancer
Published: October 03, 2025

Medication-related jaw osteonecrosis in metastatic RCC treated with VEGFR-TKIs ± IO and bone agents: A real-world analysis.

Medication-related jaw osteonecrosis in metastatic RCC treated with VEGFR-TKIs ± IO and bone agents: A real-world analysis.

Journal: Tumori
Published: August 29, 2025

Targeting Cyclin-Dependent Kinase 4 Amplifications: A Pioneering Case of Metastatic Leydig Cell Tumor Responding to Abemaciclib.

Targeting Cyclin-Dependent Kinase 4 Amplifications: A Pioneering Case of Metastatic Leydig Cell Tumor Responding to Abemaciclib.

Journal: JCO precision oncology
Published: August 18, 2025

Pathological Complete Response in Metastatic Renal Cell Carcinoma Patients Treated With Cabozantinib Plus Nivolumab. Case Series and Literature Review.

Pathological Complete Response in Metastatic Renal Cell Carcinoma Patients Treated With Cabozantinib Plus Nivolumab. Case Series and Literature Review.

Journal: Clinical genitourinary cancer
Published: February 04, 2025

Characterization of Patients with Lymph Node Only Metastatic Urothelial Carcinoma Treated with Nivolumab Plus Gemcitabine-Cisplatin Versus Gemcitabine-Cisplatin Alone from the CheckMate 901 Trial.

Characterization of Patients with Lymph Node Only Metastatic Urothelial Carcinoma Treated with Nivolumab Plus Gemcitabine-Cisplatin Versus Gemcitabine-Cisplatin Alone from the CheckMate 901 Trial.

Journal: European urology
Published: November 19, 2024
Showing 1-12 of 57

Last Updated: 09/26/2026